Sovargen

News

Angelini Pharma has licensed a preclinical-stage mTOR inhibitor from South Korean biotech Sovargen with potential for genetic forms of epilepsy.

News

Amazon Web Services has committed $100m in AI and cloud technology capacity to support the building of health services for "underserved communities."

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.